• 1. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 2. Dissociation of aryl sulfonyl phthalimide radical anions: relevance to the biological activity of arylsulfonyl amides?
  Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330
• 3. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 4. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
• 5. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Quinolines and derivatives Quinolines and derivatives
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Quinolines and derivatives

Introduction to 4-Aminomethylquinoline hydrochloride (CAS No. 1095661-17-8)

4-Aminomethylquinoline hydrochloride, identified by the Chemical Abstracts Service Number (CAS No.) 1095661-17-8, is a significant compound in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the quinoline derivatives, a class of heterocyclic aromatic organic compounds that have garnered considerable attention due to their diverse biological activities and potential therapeutic applications. The presence of both an amino group and a methyl substituent in its structure imparts unique chemical properties, making it a valuable scaffold for the development of novel bioactive molecules.

The molecular structure of 4-Aminomethylquinoline hydrochloride consists of a quinoline core, which is a fused bicyclic system comprising a benzene ring and a pyridine ring. The introduction of an amino group at the 4-position and a methyl group at the 3-position enhances its reactivity and functionality, enabling its incorporation into complex molecular architectures. This structural configuration allows for various chemical modifications, facilitating the synthesis of derivatives with tailored pharmacological properties.

In recent years, quinoline derivatives have been extensively studied for their potential in treating a wide range of diseases, including infectious diseases, cancer, and neurological disorders. The amino group in 4-Aminomethylquinoline hydrochloride serves as a versatile handle for further functionalization, enabling the attachment of pharmacophores that can interact with biological targets. Additionally, the quinoline scaffold is known for its ability to permeate biological membranes, which enhances its bioavailability and cellular uptake.

One of the most notable applications of 4-Aminomethylquinoline hydrochloride is in the development of antimicrobial agents. Quinoline derivatives have historically been used in the treatment of malaria, with chloroquine being one of the most well-known examples. The structural similarity between chloroquine and 4-Aminomethylquinoline hydrochloride suggests that it may possess comparable antimicrobial properties. Recent studies have highlighted the importance of quinoline derivatives in combating drug-resistant pathogens, making compounds like 4-Aminomethylquinoline hydrochloride promising candidates for further investigation.

Furthermore, research has indicated that 4-Aminomethylquinoline hydrochloride exhibits potential anticancer activity. The ability of quinoline derivatives to inhibit key enzymes involved in cancer cell proliferation has been well-documented. For instance, studies have shown that certain quinolines can interfere with DNA replication and transcription in cancer cells, leading to their death. The presence of both an amino group and a methyl group in 4-Aminomethylquinoline hydrochloride may enhance its binding affinity to these enzymatic targets, thereby improving its efficacy as an anticancer agent.

The synthesis of 4-Aminomethylquinoline hydrochloride involves multi-step organic reactions that typically begin with the functionalization of a quinoline precursor. The introduction of the amino group at the 4-position can be achieved through nucleophilic substitution reactions, while the methylation at the 3-position can be accomplished using methylating agents under controlled conditions. The final step involves converting the free base form into its hydrochloride salt to improve stability and solubility.

The pharmacokinetic properties of 4-Aminomethylquinoline hydrochloride are another critical aspect that has been explored in recent research. Studies have demonstrated that this compound exhibits moderate solubility in water and good bioavailability when administered orally. These characteristics make it suitable for formulation into various dosage forms, including tablets and capsules. Additionally, preliminary toxicology studies have shown that 4-Aminomethylquinoline hydrochloride is generally well-tolerated at therapeutic doses, although further studies are needed to fully assess its safety profile.

In conclusion, 4-Aminomethylquinoline hydrochloride (CAS No. 1095661-17-8) represents a promising compound in pharmaceutical research due to its unique structural features and potential therapeutic applications. Its ability to interact with biological targets makes it a valuable scaffold for drug development against infectious diseases and cancer. Ongoing research continues to explore its pharmacological properties, synthesis methods, and potential clinical applications, ensuring that it remains at the forefront of medicinal chemistry innovation.

• 3468-17-5(1H-indol-6-ylmethanamine)
• 99071-54-2(1-(quinolin-6-yl)methanamine)
• 3007-43-0(4-methyl-Quinoline hydrochloride)
• 850734-85-9(7-(Piperazin-1-yl)-2,3-dihydrothieno2,3-cpyridine Hydrochloride)
• 850734-84-8(8-Isoquinolinemethamine Dihydrochloride)
• 5632-13-3(Quinolin-4-ylmethanamine)
• 362606-12-0((Isoquinolin-8-yl)methanamine)
• 3468-18-6(1H-indol-4-ylmethanamine)
• 58123-57-2((quinolin-5-yl)methanamine)
• 157610-83-8(N-Methyl-1-quinolin-4-ylmethanamine)